Safety Study of Imexon Plus Gemcitabine in Untreated Pancreatic Adenocarcinoma
Clinical trial NCT00327327 · COMPLETED
Trial details
- NCT number
- NCT00327327
- Sponsor
- AmpliMed Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-02-01
- Primary completion
- 2009-10-01
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.